Citations

Clear

16280 citation(s) found for "Yu, David".

Somatic Genomic Profiling of Pancreatic Ductal Adenocarcinomas From a Diverse Cohort of Patients
Riner, Andrea N. , Rajpara, Seeta , Qian, Jing , Jin, Yuxin , Loza, Donna, Akki, Ashwin , Raj, Rohit , Merchant, Nipun B. , Hughes, Steven , Reams, Renee, Redda, Ken, Odedina, Folakemi T., Agyare, Edward , Craig, David W. , Carpten, John D. , Trevino, Jose , Velazquez‐Villarreal, Enrique , Herremans, Kelly M. , Williams, Terence M. , George, Thomas J. , Hughes, Steven J., Stern, Mariana Carla , Redda, Ken, Wilkie, Diana J. , Chamala, Srikar , Han, Bo

Mayo Clinic

Pancreas | February 25, 2025 | Volume: 54 | Issue: 3 | Pages: e171-e178

10.1097/mpa.0000000000002408 | PMID 39999309 Get It

Objectives Black/African American (B/AA) pancreatic ductal adenocarcinoma (PDAC) patients have worse clinical outcomes than White patients and are underrepresented in genomic databases. We aimed to expand our understanding of the PDAC somatic landscape from a diverse cohort. Materials and Methods Formalin-fixed paraffin-embedded specimens from 24 surgically resected PDAC cases were collected, with self-reported race/ethnicity. Whole exome sequencing was performed on malignant and benign tissue. Bioinformatics analysis included deduction of genetic ancestry and somatic mutational analysis, with comparisons to public datasets. Results Out of 24 cases, 17 identified as B/AA race; genetic ancestry analysis confirmed proportions of Sub-Saharan African ancestry greater than 47%. The most commonly mutated genes included KRAS , TP53 , SMAD4 , and CDKN2A . Comparison of mutations in our cohort versus publicly available, predominantly White datasets showed higher mutation frequencies of ATM, RREB1, BRCA1/2, KDM6A, ARID1A, BRAF, and MYC ( P < 0.04). When cohorts were combined and analyzed by race, no mutation frequencies differences were observed, including KRAS . Conclusions Genomic analysis of PDAC tumors from B/AA and White patients demonstrate similarities in mutation frequencies. Larger studies are needed to further understand molecular characterizations across continental subpopulations. This study provides further rationale for equitable representation of diverse patients in genomic databases and clinical trials.
Society of Anesthesia and Sleep Medicine Opinion Paper: High-Flow Nasal Oxygen Therapy for Early Postoperative Management of Patients With Sleep-Disordered Breathing
Pappu, Ameya , Auckley, Dennis , Cloward, Tom V., Dominguez, Jennifer E. , Dupuy-McCauley, Kara , Gali, Bhargavi , Gay, Peter C. , Hillman, David R. , McConville, Sarah S., Nafiu, Olubukola O. , Won, Christine , Gay, Peter, Singh, Mandeep

Mayo Clinic

Anesthesia & Analgesia | February 25, 2025 | Volume: 141 | Issue: 4 | Pages: 740-747

10.1213/ane.0000000000007424 | PMID 39998995 Get It

Warfarin Dose Management Using Offline Deep Reinforcement Learning
Ji, Hannah , Gill, Matthew, Draper, Evan , Liedl, David , Hodge, David O. , Casanegra, Ana I. , Casanegra, Ana I , Houghton, Damon E.

Mayo Clinic

IEEE Journal of Biomedical and Health Informatics | February 24, 2025 | Volume: 29 | Issue: 7 | Pages: 5219-5228

10.1109/jbhi.2025.3545384 | PMID 40031866 Get It

Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition
Fiorica, Peter N. , Golmard, Lisa , Kim, Jung , Bao, Riyue , Lin, Frank Y. , Roy, Angshumoy , Pribnow, Allison , Perrino, Melissa R. , Masliah‐Planchon, Julien , Michalak-Provost, Sophie , Wong, Jennifer , Filser, Mathilde , Bourdeaut, Franck , Brahimi, Afane, Ingster, Olivier, Jackson, Sarah A. , Sasaki, Mark M. , Fowler, Trent, Ng, Anita , Corbett, Ryan J. , Kaufman, Rebecca , Haley, Jeremy S. , Carey, David J. , Huang, Kuan‐lin , Diskin, Sharon J. , Al‐Kateb, Hussam , Schultz, Kris Ann P. , Onel, Kenan , Stoppa-Lyonnet, Dominique , Bourdeaut, Franck , Brahimi, Afane , Ingster, Olivier , Saulnier Sholler, Giselle , Jackson, Sarah A , Sasaki, Mark M , Fowler, Trent , Ng, Anita , Corbett, Ryan J , Kaufman, Rebecca S , Haley, Jeremy S , Carey, David J , Huang, Kuan-Lin , Diskin, Sharon J , Rokita, Jo Lynne , Al-Kateb, Hussam , McGee, Rose B , Schiffman, Joshua D , Chen, Kenneth S , Stewart, Douglas R , Parsons, D Williams , Plon, Sharon E. , Schultz, Kris Ann P , Onel, Kenan , Perrino, Melissa R , Lin, Frank Y , Stoppa‐Lyonnet, Dominique , Rokita, Jo Lynne , Chen, Kenneth , Parsons, D. Williams

Mayo Clinic

Clinical Cancer Research | February 24, 2025 | Volume: 31 | Issue: 8 | Pages: 1491-1503

10.1158/1078-0432.ccr-24-2785 | PMID 39992227 Get It

Abstract Purpose: DROSHA, DGCR8, and DICER1 regulate miRNA biogenesis and are commonly mutated in cancer. Although DGCR8 and DICER1 germline pathogenic variants (GPV) cause autosomal dominant tumor predisposition, no association between DROSHA GPVs and clinical phenotypes has been reported. Experimental Design: After obtaining informed consent, sequencing was performed on germline and tumor samples from all patients. The occurrence of germline DROSHA GPVs was investigated in large pediatric and adult cancer datasets. The population prevalence of DROSHA GPVs was investigated in the UK Biobank and Geisinger DiscovEHR cohorts. Results: We describe nine children from eight families with heterozygous DROSHA GPVs and a diagnosis of pineoblastoma (n = 8) or Wilms tumor (n = 1). A somatic second hit in DROSHA was detected in all eight tumors analyzed. All pineoblastoma tumors analyzed were classified as miRNA processing–altered 1 subtype. We estimate the population prevalence of germline DROSHA loss-of-function variants to be 1:3,875 to 1:4,843 but find no evidence for increased adult cancer risk. Conclusions: This is the first report of DROSHA-related tumor predisposition. As pineoblastoma and Wilms tumor are also associated with DICER1 GPVs, our results suggest that the tissues of origin for these tumors are uniquely tolerant of general miRNA loss. The miRNA processing–altered 1 pineoblastoma subtype is associated with older age of diagnosis and better outcomes than other subtypes, suggesting DROSHA GPV status may have important clinical and prognostic significance. We suggest that genetic testing for DROSHA GPVs be considered for patients with pineoblastoma, Wilms tumor, or other DICER1-/DGCR8-related conditions and propose surveillance recommendations through research studies for individuals with DROSHA GPVs.
Intracluster correlation coefficients from cluster randomized trials conducted within the NCI Community Oncology Research Program (NCORP)
Snavely, Anna C. , Lee, Ju-Whei, Pugh, Stephanie L. , Arnold, Kathryn B. , Smith, Sydney A. , Tan, Angelina D, Dockter, Travis , Zahrieh, David M. , Gunn, Heather J., Gunn, Heather , Barlow, William E. , Culakova, Eva , Kittel, Carol , Hanlon, Bret M. , Tan, Angelina D, Dressler, Emily V.

Mayo Clinic

JNCI Monographs | February 24, 2025 | Volume: 2025 | Issue: 68 | Pages: 65-72

10.1093/jncimonographs/lgae048 | PMID 39989039 Get It

Abstract The intracluster correlation coefficient (ICC) measures the correlation of observations within clusters and is a key parameter for power and sample size calculations for cluster randomized trials (CRTs). To facilitate the design of future CRTs within the National Cancer Institute Community Oncology Research Program (NCORP), all studies from the NCORP website were reviewed to identify completed CRTs. ICCs for primary and secondary outcomes (when available) were ascertained from these trials and summarized in this article as a resource for future trial development. Although ICCs are relatively small for many outcome cluster combinations, that is not always the case, so consideration should always be given to the specific outcome of interest, trial design, and type of cluster when estimating an ICC to facilitate trial development.
Practical design considerations for cluster randomized controlled trials: lessons learned in community oncology research
Dressler, Emily V. , Pugh, Stephanie L. , Zahrieh, David M. , Gunn, Heather J., Dressler, Emily V , Gunn, Heather , Unger, Joseph M. , Snavely, Anna C.

Mayo Clinic

JNCI Monographs | February 24, 2025 | Volume: 2025 | Issue: 68 | Pages: 56-64

10.1093/jncimonographs/lgae053 | PMID 39989035 Get It

Abstract Cancer care delivery research trials conducted within the National Cancer Institute (NCI) Community Oncology Research Program (NCORP) routinely implement interventions at the practice or provider level, necessitating the use of cluster randomized controlled trials (cRCTs). The intervention delivery requires cluster-level randomization instead of participant-level, affecting sample size calculation and statistical analyses to incorporate correlation between participants within a practice. Practical challenges exist in the conduct of these cRCTs due to unique trial network infrastructures, including the possibility of unequal participant accrual totals and rates and staggered study initiation by clusters, potentially with differences between randomized arms. Execution of cRCT designs can be complex, ie, if some clusters do not accrue participants, unintended cluster-level crossover occurs, how best to identify appropriate cluster-level stratification, timing of randomization, and multilevel eligibility criteria considerations. This article shares lessons learned with potential mitigation strategies from 3 NCORP cRCTs.
High-Power Short-Duration Ablation versus Conventional Power Ablation in Pulmonary Vein Isolation in Patients with Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
Cabral, David C. B. I. , Rivera, André , Braga, Marcelo Antonio Pinheiro , Passos, Bárbara Mariz Ferreira, Brígido, Alexandra Régia Dantas , Carvalho, Guilherme Dagostin de , Deshmukh, Abhishek , DeSimone, Christopher V. , DeSimone, Christopher V , Félix, Iuri Ferreira , Ternes, Caique M. P. , Rivera, A

Mayo Clinic

No container title available | February 22, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.174024725.57612852/v1 Get It

Introduction: High-power short-duration (HPSD) ablation has emerged as a promising alternative to conventional power delivery (CPD) for pulmonary vein isolation (PVI) among patients with atrial fibrillation (AF). However, its efficacy, procedural efficiency, and safety profile remain uncertain. Methods: PubMed, Embase, Cochrane Library and ClinicalTrials.Gov databases were systematically searched for randomized controlled trials (RCTs) comparing HPSD with CPD ablation for PVI in patients with AF. Random-effects models were used to pool hazard ratios (HR) and risk ratios (RR) with 95% confidence intervals (CI). R version 4.4.2 was used for statistical analysis. Results: Seven RCTs with 1,006 patients (514 HPSD, 489 CPD) were included. No significant differences were found in freedom from arrhythmia during the follow-up period (HR 0.77; 95% CI 0.41–1.45; p=0.424). AF recurrence did not differ (RR 0.94; 95% CI 0.65–1.36; p=0.733) between groups. HPSD had a significantly shorter procedural (MD -22.61 min; 95% CI -33.18, -12.04; p<0.001) and RF ablation times (MD -15.70 min; 95% CI -20.86, -10.55; p<0.001). No differences were observed in fluoroscopy time and first-pass isolation for right and left pulmonary veins. There was no difference in esophageal lesion rates, pericardial, or neurological complications, but there was a higher incidence of steam pops in HPSD (RR 3.42; 95% CI 1.45–8.09; p=0.005). Conclusion: In patients with AF undergoing PVI, HPSD did not increase freedom from arrhythmia as compared with CPD ablation, however it was associated with shorter procedure and RF ablation times with a similar safety profile.
BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma
Gutmair, Katja , Villa, Diego , Cunningham, Nicholas , Silkenstedt, Elisabeth , Rimsza, Lisa M. , Ramsower, Colleen , Scott, David W. , Dreyling, Martin , Hoster, Eva , Rimsza, Lisa, Gerrie, Alina S , Kluin-Nelemans, Hanneke C , Dreyling, Martin , Hoster, Eva , Scott, David W , Ramsower, Colleen A , Cunningham, Nicholas, Gerrie, Alina S. , Kluin‐Nelemans, Hanneke C.

Mayo Clinic

Blood Advances | February 21, 2025 | Volume: 9 | Issue: 9 | Pages: 2302-2306

10.1182/bloodadvances.2024015292 | PMID 39983085 Get It

Guiding Principles for Data Sharing and Harmonization: Results of a Systematic Review and Modified Delphi From the Society of Critical Care Medicine Data Science Campaign
Armaignac, Donna Lee , Heavner, Smith F. , Rausen, Michelle , Zhang, Xiaohan Tanner , Al-Hakim, Tamara, Strekalova, Yulia Levites , Shah, Neel , Remy, Kenneth E. , Manion, Sean T. , Scruth, Elizabeth , Rincon, Teresa , Park, Soojin , Evans, Laura , Ozrazgat‐Baslanti, Tezcan , Murphy, David J. , Engel, Heidi J., Cobb, J. Perren , Clermont, Gilles , Park, Soojin , Laudański, Krzysztof , Haendel, Melissa , Kramer, Andrew A. , Herasevich, Vitaly , Sikora, Andrea , Khanna, Ashish K. , Zimmerman, Jerry J. , Reuter‐Rice, Karin

Mayo Clinic

Critical Care Medicine | February 21, 2025 | Volume: 53 | Issue: 3 | Pages: e619-e631

10.1097/ccm.0000000000006578 | PMID 39982146 Get It

OBJECTIVES: This study aimed to establish a set of guiding principles for data sharing and harmonization in critical care, focusing on the use of real-world data (RWD) and real-world evidence (RWE) to improve patient outcomes and research efficacy. The principles were developed through a systematic literature review and a modified Delphi process, with the goal of enhancing data accessibility, standardization, and interoperability across critical care settings. DATA SOURCES: Data sources included a comprehensive search of peer-reviewed literature, specifically studies related to the use of RWD and RWE in healthcare, guidelines, best practices, and recommendations on data sharing and harmonization. A total of 8150 articles were initially identified through databases such as MEDLINE and Web of Science, with 257 studies meeting inclusion criteria. STUDY SELECTION: Inclusion criteria focused on publications discussing health-related informatics, recommendations for RWD/RWE usage, data sharing, and harmonization principles. Exclusion criteria ruled out non-human studies, case studies, conference abstracts, and articles published before 2013, as well as those not available in English. DATA EXTRACTION: From the 257 selected studies, 322 statements were extracted. After removing irrelevant definitions and off-topic content, 232 statements underwent content validation and thematic analysis. These statements were then consolidated into 24 candidate guiding principles after rigorous review and consensus-building among the expert panel. DATA SYNTHESIS: A three-phase modified Delphi process was employed, involving a conceptualization group, a review group, and a Delphi group. In phase 1, experts identified key themes and search terms for the systematic review. Phase 2 involved validating and refining the prospective guiding principles, while phase 3 employed a Delphi panel to rate principles on acceptability, importance, and feasibility. This process resulted in 24 guiding principles, with high consensus achieved in rounds 2 and 3 on their relevance and applicability. CONCLUSIONS: The systematic review and Delphi process resulted in 24 guiding principles to improve data sharing and harmonization in critical care. These principles address challenges across the data lifecycle, including generation, storage, access, and usage of RWD and RWE. This framework is designed to promote more effective and equitable data practices, with relevance for the development of artificial intelligence-based decision support tools and clinical research. The principles are intended to guide the responsible use of data science in critical care, with emphasis on ethics and equity, while acknowledging the variability of resources across settings.
Development of a Core Critical Care Data Dictionary With Common Data Elements to Characterize Critical Illness and Injuries Using a Modified Delphi Method
Anderson, Wesley R., Heavner, Smith H., Al-Hakim, Tamara, Cruz‐Cano, Raul , Engel, Heidi J., Lamb, Keith, MacLaren, Robert , Rincon, Teresa , Sikora, Andrea, Tanner, Donna, Teeter, William , Wong, An-Kwok Ian , Zhang, Xiaohan Tanner , Zimmerman, Jerry J. , Kumar, Vishakha K. , Cobb, J. Perren, Laudański, Krzysztof , Murphy, David J., Anderson, Wesley, Heavner, Smith H., Kamaleswaran, Rishikesan , Badawi, Omar , Grunwell, Jocelyn R. , Herasevich, Vitaly , Khanna, Ashish K. , Sanchez-Pinto, Lazaro Nelson , Sikora, Andrea , Stevens, Robert David , Wynn, James Lawrence , Reuter‐Rice, Karin

Mayo Clinic

Critical Care Medicine | February 21, 2025 | Volume: 53 | Issue: 5 | Pages: e1045-e1054

10.1097/ccm.0000000000006595 | PMID 39982128 Get It

OBJECTIVES: To develop the first core Critical Care Data Dictionary (C2D2) with common data elements (CDEs) to characterize critical illness and injuries. DESIGN: Group consensus process using modified Delphi approach. SETTING: Electronic surveys and in-person meetings. SUBJECTS: A multidisciplinary workgroup of clinicians and researchers with expertise in the care of the critically ill and injured. INTERVENTIONS: The Delphi process was divided into domain and CDE portions with each composed of two item generation rounds and one item reduction/refinement rounds. Two in-person meetings augmented this process to facilitate review and consideration of the domains and by panel members. The final set of domains and CDEs was then reviewed by the group to meet the competing criteria of utility and feasibility, resulting in the core dataset. MEASUREMENTS AND MAIN RESULTS: The 23-member Delphi panel was provided 1833 candidate variables for potential dataset inclusion. The final dataset includes 226 patient-level CDCs in nine domains, which include anthropometrics and demographics (8), chronic comorbid illnesses (18), advanced directives (1), ICU diagnoses (61), diagnostic tests (42), interventions (27), medications (38), objective assessments (26), and hospital course and outcomes (5). Upon final review, 91% of the panel endorsed the CDCs as meeting criteria for a minimum viable data dictionary. Data elements cross the lifespan of neonate through adult patients. CONCLUSIONS: The resulting C2D2 provides a foundation to facilitate rapid collection, analyses, and dissemination of information necessary for research, quality improvement, and clinical practice to optimize critical care outcomes. Further work is needed to validate the effectiveness of the dataset in a variety of critical care settings.